Cardinal Health, Inc. (CAH)
Industrials › Wholesale-Drugs, Proprietaries & Druggists' Sundries
Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 564% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 6/9 — moderate financial health
- ROE of 34.1% — good return on equity
Cardinal Health, Inc. (CAH) is a Industrials company operating in Wholesale-Drugs, Proprietaries & Druggists' Sundries, listed on the NYSE , with a market capitalisation of $51.1 billion . Key value metrics: P/E ratio 28.0, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Cardinal Health, Inc. — Fundamental Analysis Summary
Cardinal Health, Inc. (CAH) is currently trading 564% above its Graham Number of $32.70, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 28.0x.
On financial health, CAH shows a moderate Piotroski F-Score of 6/9, and strong return on equity of 34.1% (sector average: 5.5%), and high leverage with a debt-to-equity ratio of 3.48.
StockPik's composite Value Score for CAH is 60/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
CAH reports a thin gross margin of 3.7% (sector average: 24.7%) and a modest operating margin of 1.1%.
CAH shows revenue declining at 2% year-over-year, with earnings growing at 83%.
CAH pays a modest dividend yield of 0.9%.